Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

251
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

240
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
240
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

189
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
189
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

207
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
207
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Augmented Reality Tourism Technology Based on an Improved ORB Algorithm and Homography Matrix.

Journal of visualized experiments : JoVE·2026
Same author

Interpretable Machine Learning Model for Predicting Prolonged Postoperative Length of Stay in Lung Cancer Patients Undergoing Day Surgery: A Retrospective Cohort Study.

The Journal of craniofacial surgery·2026
Same author

Application and Effect of the Nurse-Led Pre-Hospital, Intra-Hospital, Post-Hospital Management Model in the Fine Management of Pre-Admitted Surgical Patients.

Journal of evaluation in clinical practice·2026
Same author

Innate immune activation in vitiligo: mechanisms and pathophysiological implications.

Frontiers in immunology·2025
Same author

Light-up RNA aptamer-based T-NASBA: a one-pot, label-free strategy for miRNA detection.

Analytical sciences : the international journal of the Japan Society for Analytical Chemistry·2025
Same author

Effect of computerized cognitive remediation therapy on mental time travel in patients with schizophrenia- a pilot randomized controlled trial.

Frontiers in psychiatry·2024
Same journal

A HRH1-YAP1 feedback loop drives pancreatic cancer progression and predicts therapeutic response.

Oncology letters·2026
Same journal

Application and challenges of chimeric antigen receptor T cell therapy in the treatment of acute myeloid leukemia (Review).

Oncology letters·2026
Same journal

Prognostic value of the preoperative lactate dehydrogenase-to-albumin ratio in patients with gastrointestinal cancer.

Oncology letters·2026
Same journal

Erratum: [Corrigendum] Wentilactone A induces cell apoptosis by targeting AKR1C1 gene via the IGF-1R/IRS1/PI3K/AKT/Nrf2/FLIP/Caspase-3 signaling pathway in small cell lung cancer.

Oncology letters·2026
Same journal

Erratum: [Corrigendum] Overexpression of lncRNA AFAP1-AS1 promotes cell proliferation and invasion in gastric cancer.

Oncology letters·2026
Same journal

Erratum: [Corrigendum] Temozolomide abrogates the aggressiveness of urothelial carcinoma cells by enhancing senescence and depleting the side population.

Oncology letters·2026
See all related articles

Related Experiment Videos

Pediatric sarcomas.

Junhua Cao, Qi An, Lei Wang

    Oncology Letters
    |March 24, 2018
    PubMed
    Summary
    This summary is machine-generated.

    This study is retracted. The article, identified by DOI 10.3892/ol.2017.7467, has been withdrawn from publication.

    Related Experiment Videos

    Area of Science:

    • Not applicable as this is a retraction notice.

    Background:

    • Not applicable as this is a retraction notice.

    Purpose of the Study:

    • To formally retract the article with DOI: 10.3892/ol.2017.7467.

    Main Methods:

    • Not applicable as this is a retraction notice.

    Main Results:

    • The article has been retracted.

    Conclusions:

    • The article is no longer considered part of the scientific record.